These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 21977582)
1. [Construction and recovery of chimeric rabies virus expressing envelop proteins E1E2 of hepatitis C]. Du JL; Huang Y; Tang Q; Wang LH; Liang GD Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):170-2. PubMed ID: 21977582 [TBL] [Abstract][Full Text] [Related]
2. [The function of helper plasmids from HEP-Flury strain rabies virus on encapsidating the full-length genome of CTN strain]. Huang Y; Tang Q; Hu RL Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):493-6. PubMed ID: 19799148 [TBL] [Abstract][Full Text] [Related]
3. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines. Siler CA; McGettigan JP; Dietzschold B; Herrine SK; Dubuisson J; Pomerantz RJ; Schnell MJ Virology; 2002 Jan; 292(1):24-34. PubMed ID: 11878905 [TBL] [Abstract][Full Text] [Related]
4. [Preparation and identification of a recombinant hepatitis C virus (HCV) based on sindbis virus vector]. Fu JJ; Zhu WY; Li JJ; Wang HQ; Tan WJ; Yin JZ; Liang GD Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):136-8. PubMed ID: 23002557 [TBL] [Abstract][Full Text] [Related]
6. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Vietheer PT; Boo I; Drummer HE; Netter HJ Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556 [TBL] [Abstract][Full Text] [Related]
7. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast. Cai W; Su L; Liao Q; Ye L; Wu Y; Wu Z; She Y Antiviral Res; 2010 Oct; 88(1):80-5. PubMed ID: 20691736 [TBL] [Abstract][Full Text] [Related]
8. [Characterization of Serial Passage of 1b/2a Chimera Hepatitis C Virus Cell Culture System Carrying Envelope E1E2 Coding Gene from Hebei Strain of China]. Lu S; Zhang L; Tao G; Cai M; Bao Lili ; LI L; Deng Y; Shen X; Tan W Bing Du Xue Bao; 2015 Nov; 31(6):647-52. PubMed ID: 26951010 [TBL] [Abstract][Full Text] [Related]
9. Development of a reverse genetics system for a human rabies virus vaccine strain employed in China. Huang Y; Tang Q; Nadin-Davis SA; Zhang S; Hooper CD; Ming P; Du J; Tao X; Hu R; Liang G Virus Res; 2010 Apr; 149(1):28-35. PubMed ID: 20080136 [TBL] [Abstract][Full Text] [Related]
10. Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein. Okuma K; Fukagawa K; Tateyama S; Kohma T; Mochida K; Hiyoshi M; Takahama Y; Hamaguchi Y; Hirose K; Buonocore L; Rose JK; Mizuochi T; Hamaguchi I Jpn J Infect Dis; 2015; 68(3):203-8. PubMed ID: 25672345 [TBL] [Abstract][Full Text] [Related]
11. Development of recombinant rabies viruses vectors with Gaussia luciferase reporter based on Chinese vaccine strain CTN181. Du J; Tang Q; Huang Y; Rodney WE; Wang L; Liang G Virus Res; 2011 Sep; 160(1-2):82-8. PubMed ID: 21645562 [TBL] [Abstract][Full Text] [Related]
12. Purification and application of bacterially expressed chimeric protein E1E2 of hepatitis C virus. Xiang ZH; Cai WJ; Zhao P; Kong LB; Ye LB; Wu ZH Protein Expr Purif; 2006 Sep; 49(1):95-101. PubMed ID: 16600629 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains. Lin X; Zhang Y; Bi S; Lu J; Zhao H; Tan W; Li D; Wang Y Biochem Biophys Res Commun; 2009 Jul; 385(2):257-62. PubMed ID: 19464265 [TBL] [Abstract][Full Text] [Related]
14. Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease. Hamed MR; Tarr AW; McClure CP; Ball JK; Hickling TP; Irving WL J Viral Hepat; 2008 May; 15(5):339-45. PubMed ID: 18221305 [TBL] [Abstract][Full Text] [Related]
15. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus]. Wang YZ; Zhang SF; Hu RL; Wang X; Xiao YQ Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):213-7. PubMed ID: 15989263 [TBL] [Abstract][Full Text] [Related]
16. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies. Patient R; Hourioux C; Vaudin P; Pagès JC; Roingeard P N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein. Yang D; Meng X; Yu Q; Xu L; Long Y; Liu B; Fang X; Zhu H Antimicrob Agents Chemother; 2013 Oct; 57(10):4937-44. PubMed ID: 23877701 [TBL] [Abstract][Full Text] [Related]
18. Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development. Desjardins D; Huret C; Dalba C; Kreppel F; Kochanek S; Cosset FL; Tangy F; Klatzmann D; Bellier B J Gene Med; 2009 Apr; 11(4):313-25. PubMed ID: 19248137 [TBL] [Abstract][Full Text] [Related]
19. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396 [TBL] [Abstract][Full Text] [Related]
20. [Construction of helper plasmids used in reverse genetic system of a cell adapted rabies virus strain]. Huang Y; Hu RL; Tang Q Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):247-50. PubMed ID: 19105333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]